Clinical Trials Directory

Trials / Unknown

UnknownNCT04915573

Antimicrobial Resistance in Cirrhotic Patients

Antimicrobial Resistance Among Sputum Pathogens in Post Hepatitis Cirrhotic Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Cirrhotic patients are more vulnerable to bacterial infection, and infection is one of the most common causes of acute liver disease decompensation.

Detailed description

Cirrhotic patients are more vulnerable to bacterial infection which is a common cause of acute liver disease decompensation. The aim of this study will characterize the antimicrobial resistance and distribution of bacteria isolated from chronic hepatic patients with pulmonary infections, as well as to evaluate the antimicrobial susceptibility of bacteria isolated from sputum.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSpecimenSputum will be collected in clean disposable containers

Timeline

Start date
2021-06-07
Primary completion
2021-09-01
Completion
2021-09-01
First posted
2021-06-07
Last updated
2021-06-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04915573. Inclusion in this directory is not an endorsement.